Measles epidemic--Majuro Atoll, Republic of the Marshall Islands, July 13-September 13, 2003.
A total of 58 persons with measles have been hospitalized; three patients have died, including a malnourished child aged 15 months with diarrhea and pneumonia, a woman aged 27 years with pneumonia, and a woman aged 39 years whose immediate cause of death remains unknown. Postmortem examination was not available for any of these patients.
To stop measles transmission, the Ministry of Health in RMI recommended measles, mumps, and rubella vaccine (MMR) for all infants aged 6-11 months and all persons aged 1-40 years who did not have documented proof of measles immunity ([dagger]). Before the epidemic, estimated vaccine coverage with 1 dose of MMR was <75% for children aged 1-13 years, according to evaluations of computerized vaccination records and of children screened during the vaccination campaign. As of September 13, a total of 98% of persons aged 6 months-40 years had documentation of receipt of at least 1 dose of MMR. Campaign activities that delivered 16,913 doses included 1) vaccinating health-care and public health workers, 2) vaccinating children at nine vaccination posts across the atoll, 3) delaying the start of the school year until school children were vaccinated and requiring documentation of vaccination for school entry, and 4) conducting neighborhood and house-to-house vaccination in areas where adequate coverage was not reached.
To prevent spread from Majuro Atoll, vaccination campaigns were conducted in other atolls and islands in RMI. The Ministry of Health suspended travel of sea vessels and airlines from Majuro Atoll until vaccination campaigns had been completed in other atolls and islands, and required proof of MMR vaccination for all travelers leaving Majuro Atoll for other atolls or islands or for international destinations. A total of 17 measles cases have been reported from Ebeye Island in Kwajalein Atoll; 10 of these persons were exposed in Majuro Atoll. Two other atolls have reported six cases whose exposure was in Majuro Atoll. Measles surveillance has been enhanced in RMI, other Pacific islands, and in the United States. Spread to other areas in the Pacific and to the United States has been limited; five measles cases in Hawaii, three in Guam, one in Palau, and one in California are believed to be linked to this epidemic.
The source of importation of the measles virus to Majuro Atoll has not yet been determined, but the H1 genotype found in this outbreak is common in Asia, and the specific strain has been reported recently in measles cases from Japan and China (1,2). The Advisory Committee on Immunization Practices recommends that all international travelers be immune to measles because it is endemic or epidemic in many parts of the world, including developed countries (3,4). Persons aged <40 years who are traveling to RMI during the next 60 days should be aware that R/VII requires documentation of measles immunity for all departing passengers on international flights. The documentation must fulfill the same age-specific requirements used in the vaccination campaign.
This report is based on data contributed by P Asuo, MD, J Gancio, MD, H Emil, S Alfred, B Pharm, Majuro Hospital, Delap, Majuro Atoll, Republic of the Marshall Islands.
* Defined as a case in a person with fever, a generalized maculopapular rash, and cough, coryza, or conjunctivitis.
([dagger]) Persons aged 12 months-18 years required documented history of 2 doses of MMR, with the first dose administered on or after the first birthday and the second dose at least 28 days after the first dose; otherwise, these persons received either their first or second dose as indicated. Persons aged >18 years required documented history of measles or 1 dose of MMR administered on or after the first birthday; otherwise, these persons received 1 dose of MMR.
(1.) Zhou J, Fujino M, Inou Y, et al. H1 genotype of measles virus was detected in outbreaks in Japan after 2000. J Med Virol 2003;70:642-8.
(2.) Rota PA, Rota JS, Redd S, Papania M, Bellini WJ. Genetic analysis of measles viruses isolated in the United States 1989-2001 : absence of an endemic genotype since 1994. J Infect Dis (in press).
(3.) CDC. Health Information for International Travel, 2003-2004. Atlanta, Georgia: U.S. Department of Health and Human Services, Public Health Service, 2003.
(4.) CDC. Measles, mumps, and rubella-vaccine use and strategies for elimination of measles, rubella and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1998;47(No. RR-8).
J Langridrik, MPH, R Edwards, MPH, K Briand, MBBS, M Konelios, H Neamon, F Nathan, Ministry of Health. A Khalifah, Div of Applied Public Health Training, Epidemiology Program Office; H Nguyen, MPH, Epidemiology and Surveillance Div; Immunization Svcs Div, National Immunization Program; Div of Viral and Rickettsial Diseases, National Center for Infectious Diseases; M Marin, MD, R Nandy, MBBS, EIS officers, CDC.
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Public Health Dispatch|
|Author:||Langridrik, J; Edwards, R; Briand, K; Konelios, M; Neamon, H; Nathan, F; Khalifah, A; Nguyen, H; Mar|
|Publication:||Morbidity and Mortality Weekly Report|
|Date:||Sep 19, 2003|
|Previous Article:||Knowledge, attitudes, and behaviors about West Nile virus--Connecticut, 2002.|
|Next Article:||West Nile virus activity--United States, September 11-17, 2003.|